Surfactant-stripped micelle compositions with high cargo to surfactant ratio
Provided are compositions and methods relating to hydrophobic agent loaded-micelle. The micelles comprise surfactant (such as poloxamer) and have hydrophobic agents incorporated therein. The compositions substantially lack surfactant that is not associated with the micelles. The compositions are able to achieve high hydrophobic agent: surfactant molar ratio. The compositions can be used for drug delivery and imaging applications.
1. An aqueous composition comprising micelles, said micelles comprising poloxamer and encapsulating one or more hydrophobic agents thereby forming hydrophobic agent-loaded poloxamer micelles, wherein the hydrophobic agent:poloxamer molar ratio in the composition is at least 3:1 and at least 95% of the poloxamer in the composition forms the hydrophobic agent-loaded micelles.
2. The composition of claim 1 , wherein at least 96, 97, 98 or 99% of the poloxamer molecules in the formulation are present in hydrophobic agent-loaded micelles.
3. The composition of claim 1 , wherein the hydrophobic agent is a drug and the drug:poloxamer molar ratio is from 7:1 to 60:1.
4. The composition of claim 1 , wherein the hydrophobic agent is an optical contrast dye and the of dye:poloxamer molar ratio is from 3:1 to 10:1.
5. The composition of claim 1 , wherein the poloxamer is F127, F68, F108 or a mixture thereof.
6. The composition of claim 1 , wherein the hydrophobic agent has an octanol-water partition coefficient of at least 3.
7. The composition of claim 1 , wherein the hydrophobic agent is a drug selected from the group consisting of Alpha-Tocopherol, Abafungin, Amiodarone, Azithromycin Dihydrate, Bepridil, Beta-carotene, Budesonide, Cabazitaxel, Carbamazepine, Calciferol, Carvedilol, Chloroquine, Chlorpromazine, Cholecalciferol, Clotrimazole, Coenzyme Q10, Cotinine, Cyclizine, Cyclosporine A, Diazepam, Docetaxel, Econazole, Ergocalciferol, Etoposide, Fentanyl, Fenofibrate, Finasteride, Fulvestrant, Haloperidol, Haloperidol decanoate, Itraconazole, Ivermectin, Labetalol, Latanoprost, Meloxicam, Miconazole, Mifepristone, Mycophenolate mofetil, Nimodipine, Paclitaxel, Phenytoin, Piroxicam, Pregnenolone, Pregnenolone Acetate, Progesterone, Propofol, Reserpine, Retinol, Retinol Palmitate, Sertaconazole, Sibutramine, Simvastin, Sirolimus, Squalene, Tacrolimus, Tamoxifen , Temsirolimus, Testosterone, Testosterone cypionate, Testosterone priopionate, Testosterone undecanoate, Tipranavir, Travoprost, Triamcinolone, Vitamin K1, and combinations thereof.
8. The composition of , claim 1 , wherein the hydrophobic agent is an optical contrast dye selected from the categories of phthalocyanine (Pc), naphthalocyanine (Nc), chlorin, porphyrin, and bacteriochlorin.
9. A method for making a composition comprising micelles suitable for transport of hydrophobic agents comprising:
a) contacting a hydrophobic agent dissolved in organic solvent with an aqueous solution of poloxamer thereby forming hydrophobic agent-loaded poloxamer micelles;
b. causing poloxamer molecules which are not forming hydrophobic agent-loaded micelles to become unitary poloxamer units by exposure to a temperature from −20° C. to 10° C.; and
c. removing the unitary poloxamer units to result in hydrophobic agent-loaded micelle, wherein at least 85% of the poloxamer molecules are removed, wherein the hydrophobic agent:poloxamer molar ratio is from 3:1 to 60:1, and wherein 95% or more poloxamer in the composition is present in hydrophobic agent-loaded micelles.
10. The method of claim 9 , wherein the organic solvent in a) is at a concentration of 10-200 mg/mL and the aqueous solution of poloxamer is at a concentration of 5-15% (w/v).
11. The method of claim 9 , wherein the hydrophobic agent is a drug and the hydrophobic agent:poloxamer molar ratio in c) is 10:1 to 60:1.
12. The method of claim 9 , wherein the hydrophobic agent is a imaging contrast dye and the hydrophobic agent:poloxamer molar ratio in c) is 3:1 to 10:1.
13. The method of claim 9 , further comprising freeze-drying the composition from c).
14. A hydrophobic agent-loaded micelle composition made by the method of claim 9 .
15. A method of drug delivery comprising:
a) obtaining a hydrophobic drug-loaded micelle composition of claim 3 ;
b) administering to an individual the micelle composition.
16. A method for imaging at least a portion of the gastrointestinal (GI) tract in an individual comprising:
a) obtaining a hydrophobic dye-loaded micelle composition of claim 4 , wherein the dye is suitable for imaging;
b) administering to an individual via oral route the dye loaded micelle composition; and c) after a suitable period of time after administration, obtaining one or more images of the GI tract using photoacoustic or positron emission tomography imaging.
17. The method of claim 16 , wherein the dye is 2,11,20,29-tetra-tert-butyl-2,3-naphthalocyanine (BNc), Zinc-2,11,20,29-tetra-tert-butyl-2,3-naphthalocyanine (ZnBNc), 5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine (ONc),Nickel-5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine (NiONc), Vanadyl 2,11,20,29-tetra-tert-butyl-2,3-naphthalocyanine (VBNc), 2,9,16,23-tetra-tert-butyl-29H,31H-phthalocyanine (BPc), Vanadyl 3,10,17,24-tetratert-butyl-1,8,15,22-tetrakis(dimethylamino)-29H,31H-phthalocyanine (VBPc), or a combination thereof.